Generic Name and Formulations:
Fluorouracil 0.5% (0.35% in microspheres); crm.
Valeant Pharmaceuticals, Inc
Indications for CARAC:
Multiple actinic or solar keratoses of the face and anterior scalp.
≥18yrs: Wash and dry area. Wait 10 minutes. Apply thin film to skin where lesions appear once daily for up to 4 weeks. Do not occlude. May apply sunscreen/ moisturizer 2 hours later. Wash hands after use.
<18yrs: not recommended.
Dihydropyrimidine dehydrogenase (DPD) deficiency. Women of childbearing potential. Pregnancy (Cat.X).
Discontinue if symptoms of DPD deficiency develop (e.g., abdominal pain, bloody diarrhea, vomiting, fever, chills). Ulcerated or inflamed skin. Avoid eyes, mucous membranes, exposure to sun or UV light. Nursing mothers: not recommended.
Application site reaction (may persist 2 weeks after drug is stopped), eye irritation.
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Elevated Dopamine Synthesis Capacity Observed in Both Bipolar and Schizophrenia
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Specialty Physicians Experiencing Lack of Income Growth
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV